Cargando…
Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells: An Eotaxin and STAT6-dependent Process
Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens. Many tumors, however, have been immunoselected to evade recognition by CTLs and thus alternative approaches to cancer immunotherapy are urgently needed....
Autores principales: | Mattes, Joerg, Hulett, Mark, Xie, Wei, Hogan, Simon, Rothenberg, Marc E., Foster, Paul, Parish, Christopher |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193835/ https://www.ncbi.nlm.nih.gov/pubmed/12566422 http://dx.doi.org/10.1084/jem.20021683 |
Ejemplares similares
-
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
por: Rothenberg, Marc E., et al.
Publicado: (1997) -
Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals
por: Villarino, Alejandro V., et al.
Publicado: (2007) -
Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes
por: Forssmann, Ulf, et al.
Publicado: (1997) -
LACK OF A CORRELATION BETWEEN CELL-MEDIATED IMMUNITY TO THE CARRIER AND THE CARRIER-HAPTEN HELPER EFFECT
por: Liew, F. Y., et al.
Publicado: (1974) -
Immature Dendritic Cells Acquire Cd8(+)Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli
por: Schuurhuis, Danita H., et al.
Publicado: (2000)